2ʹ-Deoxyadenosine 5ʹ-diphosphoribose is an endogenous TRPM2 superagonist
Transient receptor potential melastatin 2 (TRPM2), is a ligand-gated Ca2+-permeable non19 selective cation channel. While physiological stimuli, e.g. chemotactic agents, evoke controlled Ca2+ signals via TRPM2, pathophysiological signals, such as reactive oxygen species or genotoxic stress result in...
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
Nature Publishing Group
2017
|
| _version_ | 1797104261095489536 |
|---|---|
| author | Fliegert, R Bauche, A Pérez, A Watt, J Rozewitz, M Winzer, R Janus, M Gu, F Rosche, A Harneit, A Flato, M Moreau, C Kirchberger, T Wolters, V Potter, B Guse, A |
| author_facet | Fliegert, R Bauche, A Pérez, A Watt, J Rozewitz, M Winzer, R Janus, M Gu, F Rosche, A Harneit, A Flato, M Moreau, C Kirchberger, T Wolters, V Potter, B Guse, A |
| author_sort | Fliegert, R |
| collection | OXFORD |
| description | Transient receptor potential melastatin 2 (TRPM2), is a ligand-gated Ca2+-permeable non19 selective cation channel. While physiological stimuli, e.g. chemotactic agents, evoke controlled Ca2+ signals via TRPM2, pathophysiological signals, such as reactive oxygen species or genotoxic stress result in prolonged TRPM2-mediated Ca2+ entry and consequently apoptosis. To date, adenosine 5ʹ-diphosphoribose (ADPR, 1) has been assumed to be the main agonist for TRPM2. Here, we show that 2ʹ-deoxy-ADPR 2 was a significantly better TRPM2 agonist, inducing 10.4-fold 24 higher whole cell currents at saturation. Mechanistically, this increased activity was caused by decreased rate of inactivation and higher average open probability. Using high performance liquid chromatography (HPLC) and mass spectrometry, endogenous 2ʹ-deoxy-ADPR was detected in Jurkat T-lymphocytes. Consistently, cytosolic nicotinamide mononucleotide adenylyltransferase 2 (NMNAT-2) and nicotinamide adenine dinucleotide (NAD)-glycohydrolase CD38 sequentially catalyzed synthesis of 2ʹ-deoxy- ADPR from nicotinamide mononucleotide and 2ʹ-deoxy-ATP in vitro. Thus, 2ʹ-deoxy-ADPR is an endogenous TRPM2 superagonist that may act as cell signaling molecule. |
| first_indexed | 2024-03-07T06:31:25Z |
| format | Journal article |
| id | oxford-uuid:f61d0a49-009b-43d8-ac57-cf16d286f0e5 |
| institution | University of Oxford |
| last_indexed | 2024-03-07T06:31:25Z |
| publishDate | 2017 |
| publisher | Nature Publishing Group |
| record_format | dspace |
| spelling | oxford-uuid:f61d0a49-009b-43d8-ac57-cf16d286f0e52022-03-27T12:32:39Z2ʹ-Deoxyadenosine 5ʹ-diphosphoribose is an endogenous TRPM2 superagonistJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:f61d0a49-009b-43d8-ac57-cf16d286f0e5Symplectic Elements at OxfordNature Publishing Group2017Fliegert, RBauche, APérez, AWatt, JRozewitz, MWinzer, RJanus, MGu, FRosche, AHarneit, AFlato, MMoreau, CKirchberger, TWolters, VPotter, BGuse, ATransient receptor potential melastatin 2 (TRPM2), is a ligand-gated Ca2+-permeable non19 selective cation channel. While physiological stimuli, e.g. chemotactic agents, evoke controlled Ca2+ signals via TRPM2, pathophysiological signals, such as reactive oxygen species or genotoxic stress result in prolonged TRPM2-mediated Ca2+ entry and consequently apoptosis. To date, adenosine 5ʹ-diphosphoribose (ADPR, 1) has been assumed to be the main agonist for TRPM2. Here, we show that 2ʹ-deoxy-ADPR 2 was a significantly better TRPM2 agonist, inducing 10.4-fold 24 higher whole cell currents at saturation. Mechanistically, this increased activity was caused by decreased rate of inactivation and higher average open probability. Using high performance liquid chromatography (HPLC) and mass spectrometry, endogenous 2ʹ-deoxy-ADPR was detected in Jurkat T-lymphocytes. Consistently, cytosolic nicotinamide mononucleotide adenylyltransferase 2 (NMNAT-2) and nicotinamide adenine dinucleotide (NAD)-glycohydrolase CD38 sequentially catalyzed synthesis of 2ʹ-deoxy- ADPR from nicotinamide mononucleotide and 2ʹ-deoxy-ATP in vitro. Thus, 2ʹ-deoxy-ADPR is an endogenous TRPM2 superagonist that may act as cell signaling molecule. |
| spellingShingle | Fliegert, R Bauche, A Pérez, A Watt, J Rozewitz, M Winzer, R Janus, M Gu, F Rosche, A Harneit, A Flato, M Moreau, C Kirchberger, T Wolters, V Potter, B Guse, A 2ʹ-Deoxyadenosine 5ʹ-diphosphoribose is an endogenous TRPM2 superagonist |
| title | 2ʹ-Deoxyadenosine 5ʹ-diphosphoribose is an endogenous TRPM2 superagonist |
| title_full | 2ʹ-Deoxyadenosine 5ʹ-diphosphoribose is an endogenous TRPM2 superagonist |
| title_fullStr | 2ʹ-Deoxyadenosine 5ʹ-diphosphoribose is an endogenous TRPM2 superagonist |
| title_full_unstemmed | 2ʹ-Deoxyadenosine 5ʹ-diphosphoribose is an endogenous TRPM2 superagonist |
| title_short | 2ʹ-Deoxyadenosine 5ʹ-diphosphoribose is an endogenous TRPM2 superagonist |
| title_sort | 2 deoxyadenosine 5 diphosphoribose is an endogenous trpm2 superagonist |
| work_keys_str_mv | AT fliegertr 2ʹdeoxyadenosine5ʹdiphosphoriboseisanendogenoustrpm2superagonist AT bauchea 2ʹdeoxyadenosine5ʹdiphosphoriboseisanendogenoustrpm2superagonist AT pereza 2ʹdeoxyadenosine5ʹdiphosphoriboseisanendogenoustrpm2superagonist AT wattj 2ʹdeoxyadenosine5ʹdiphosphoriboseisanendogenoustrpm2superagonist AT rozewitzm 2ʹdeoxyadenosine5ʹdiphosphoriboseisanendogenoustrpm2superagonist AT winzerr 2ʹdeoxyadenosine5ʹdiphosphoriboseisanendogenoustrpm2superagonist AT janusm 2ʹdeoxyadenosine5ʹdiphosphoriboseisanendogenoustrpm2superagonist AT guf 2ʹdeoxyadenosine5ʹdiphosphoriboseisanendogenoustrpm2superagonist AT roschea 2ʹdeoxyadenosine5ʹdiphosphoriboseisanendogenoustrpm2superagonist AT harneita 2ʹdeoxyadenosine5ʹdiphosphoriboseisanendogenoustrpm2superagonist AT flatom 2ʹdeoxyadenosine5ʹdiphosphoriboseisanendogenoustrpm2superagonist AT moreauc 2ʹdeoxyadenosine5ʹdiphosphoriboseisanendogenoustrpm2superagonist AT kirchbergert 2ʹdeoxyadenosine5ʹdiphosphoriboseisanendogenoustrpm2superagonist AT woltersv 2ʹdeoxyadenosine5ʹdiphosphoriboseisanendogenoustrpm2superagonist AT potterb 2ʹdeoxyadenosine5ʹdiphosphoriboseisanendogenoustrpm2superagonist AT gusea 2ʹdeoxyadenosine5ʹdiphosphoriboseisanendogenoustrpm2superagonist |